Exploring effects of Souvenaid on cerebral glucose metabolism in Alzheimer's disease

INTRODUCTION: Alzheimer's disease (AD) is associated with synapse loss. Souvenaid, containing the specific nutrient combination Fortasyn Connect, was designed to improve synapse formation and function. The NL-ENIGMA study explored the effect of Souvenaid on synapse function in early AD by asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Scheltens, Nienke M.E., Briels, Casper T., Yaqub, Maqsood, Barkhof, Frederik, Boellaard, Ronald, van der Flier, Wiesje M., Schwarte, Lothar A., Teunissen, Charlotte E., Attali, Amos, Broersen, Laus M., van Berckel, Bart N.M., Scheltens, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Featured Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804721/
https://www.ncbi.nlm.nih.gov/pubmed/31650005
http://dx.doi.org/10.1016/j.trci.2019.08.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804721/
https://www.ncbi.nlm.nih.gov/pubmed/31650005
http://dx.doi.org/10.1016/j.trci.2019.08.002

Ejemplares similares